| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |